Growth Metrics

Verastem (VSTM) Shares Outstanding (Diluted Average) (2016 - 2025)

Verastem's quarterly Shares Outstanding (Diluted Average) came in at $69.3 million in Q4 2025, up 94.07% year-on-year from $35.7 million in Q4 2024, and up 7.35% quarter-over-quarter from $64.6 million in Q3 2025.

Verastem has reported Shares Outstanding (Diluted Average) for 10 years, with the latest figure at $69.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 94.07% year-over-year to $69.3 million; the trailing twelve-month figure through Dec 2025 stood at $69.3 million (up 94.07% YoY), and the FY2025 full-year result was $69.3 million, up 94.07% from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 stood at $69.3 million, up from $64.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $200.7 million in Q1 2023, with the low at $14.5 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $96.6 million, with a median of $64.6 million recorded in 2025.
  • Year-over-year, Shares Outstanding (Diluted Average) surged 9379.55% in 2021 and plunged 89.24% in 2023.
  • Tracing VSTM's Shares Outstanding (Diluted Average) over 5 years: stood at $14.5 million in 2021, then climbed by 11.03% to $16.1 million in 2022, then soared by 36.66% to $22.1 million in 2023, then soared by 61.93% to $35.7 million in 2024, then jumped by 94.07% to $69.3 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $69.3 million (Q4 2025), $64.6 million (Q3 2025), and $54.2 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 3.06 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 138.23 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 69.31 Mn
Sep 30, 2025 64.56 Mn
Mar 31, 2025 54.17 Mn
Dec 31, 2024 35.71 Mn
Sep 30, 2024 31.35 Mn
Mar 31, 2024 26.83 Mn
Dec 31, 2023 22.05 Mn
Sep 30, 2023 20.45 Mn
Mar 31, 2023 200.68 Mn
Dec 31, 2022 16.14 Mn
Sep 30, 2022 190.00 Mn
Jun 30, 2022 186.36 Mn
Mar 31, 2022 186.26 Mn
Dec 31, 2021 14.54 Mn
Sep 30, 2021 179.86 Mn
Jun 30, 2021 171.99 Mn
Mar 31, 2021 171.59 Mn
Dec 31, 2020 153,330.00
Sep 30, 2020 147.77 Mn
Dec 31, 2019 74.58 Mn
Sep 30, 2019 73.99 Mn
Jun 30, 2019 73.88 Mn
Mar 31, 2019 73.85 Mn
Dec 31, 2018 69.32 Mn
Sep 30, 2018 73.64 Mn
Jun 30, 2018 61.26 Mn
Mar 31, 2018 50.84 Mn
Dec 31, 2017 38.42 Mn
Dec 31, 2016 36.99 Mn